Australia: Health Alert: 5 March 2012

Last Updated: 11 March 2012
Article by Anthony Willis


Western Australia. State Administrative Tribunal

Medical Board of Australia and Wild [2012] WASAT 37 (27 February 2012)

The Medical Board of Australia brought an application in the State Administrative Tribunal of Western Australia (Tribunal) against Dr Felicity Wild, alleging that she acted improperly by having an inappropriate personal relationship with a patient and that she acted carelessly by leaving the patient while he was suffering from an overdose of morphine without seeking or providing medical assistance.

Dr Wild agreed that conditions should be imposed on her registration and the parties prepared Minutes of Orders prior to the hearing. These outlined a number of conditions to be placed on Dr Wild's registration, including (amongst others) only providing treatment at her practice during specific hours (unless in emergencies), only maintaining one set of clinical notes for each patient and holding these notes only at her practice, and certain supervision requirements.

The Tribunal found that Dr Wild acted improperly and carelessly and ordered that the conditions (as agreed) should be placed on Dr Wild's registration. The Tribunal also ordered that Dr Wild's registration be suspended for a period of three months. The Tribunal outlined that the purpose of the suspension was not to protect the public from an incompetent practitioner, but to assure the public and members of the medical profession that such conduct will not be tolerated.



National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2012 (No. PB 9 of 2012) - F2012L00438 " PB 9 of 2012 as made

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2012 (No. 1) (No. PB 8 of 2012) - F2012L00437 " PB 8 of 2012 as made

Health Insurance (Review of GP Mental Health Treatment Plan) Revocation Determination 2012 - F2012L00436 " as made

Australian Capital Territory

Transplantation and Anatomy Amendment Act 2012 (ACT) - Assent: 29 February 2012


Drugs, Poisons and Controlled Substances Amendment (Supply by Midwives) Bill 2012 - Legislative Assembly 28 February 2012: Introduced and read a first time


Australia. Department of Health & Ageing

Media releases

Private Health Insurance Circulars

Australia. Private Health Insurance Administration Council

2 March 2012 - Industry Consultation Opportunity - Proposed Outsourcing Standard for Private Health Insurers - Current Edition - 12/04

Australian Institute of Health & Welfare

2 March 2012 - National Bowel Cancer Screening Program monitoring report: phase 2, July 2008-June 2011 (media release)

Australian Competition & Consumer Commission (ACCC)

Capped fees for after-hours medical care in ACT to continue - The ACCC has authorised CALMS Ltd, the after-hours locum medical service which operates in the ACT.

Australia. Therapeutic Goods Administration

2 March 2012 - Poly Implant Prothese (PIP) breast implants - TGA update - Updated information on safety concerns with PIP breast implants.

2 March 2012 - Update to testing results of PIP breast implants - The Therapeutic Goods Administration (TGA) has increased the number of samples of PIP breast implants tested for shell integrity by measuring the tensile elongation of a further seven samples to the original eight samples that were tested in 201.0

2 March 2012 - Documents released under Section 11C of the Freedom of Information Act 1982 (Cth) - Added FOI 142-1112 documents.

1 March 2012 - King warns against internet medicine purchases - The Hon Catherine King MP.

1 March 2012 - Update to herbal ingredient names - A notice to sponsors on updating the names of ingredients that are currently included in medicines on the Australian Register of Therapeutic Goods (ARTG).

29 February 2012 - Conformity assessment procedures for immunohaematology reagents - This guideline addresses some specific requirements in the regulation of immunohaematology reagents that manufacturers and sponsors need to consider when applying conformity assessment procedures or making applications for inclusion in the ARTG.

29 February 2012 - Information about weight loss product - The TGA will be making a final decision on the weight loss product, the SUPPREXXA Hunger Buster kit, after consideration of material provided by the sponsor, Chika Health Pty Ltd, in support of the claims made about the kit.

Australian National Health & Medical Research Council

27 February 2012 - Australia/Singapore to host leaders in emerging infectious diseases - The brightest minds in emerging infectious diseases research and current technologies have gathered in Singapore for a scientific symposium to discuss the health challenges facing the Asia Pacific. A joint initiative between the National Health and Medical Research Council and the Singapore-based Agency for Science, Technology and Research, the symposium will focus on tuberculosis, influenza and how to combat them.

Australian Capital Territory. Department of Health

Media release

1 March 2012 - Emergency Services News Alerts - For the latest local information about the impact of the wet weather, please visit the ACT Emergency Services website.

27 February 2012 - Improve your health with BEAT IT! - Join the new BEAT IT: Physical Activity and Lifestyle Program, which kicks off on Wednesday 7 March in Bruce.

New South Wales. Ministry of Health

Media releases

Rural Surgery Futures Report 2011-2021

Information bulletin

Northern Territory. Department of Health

Media release

South Australia. Department of Health

Media releases

Tasmania. Department of Health & Human Services

Media releases

Victoria. Department of Health

2 March 2012 - Environmental sustainability and climate adaptation in healthcare - The Department of Health has adopted an overarching set of Sustainability Principles that commits it to respond to the challenges of a changing climate and embed sustainability within its core business.

1 March 2012 - Box Hill breakthrough for leukaemia patients - When Adam Bregu was diagnosed with cancer during the final stages of his VCE, he was determined to get through it – by being treated like a child.

Western Australia. Department of Health

Media releases

New Zealand. Ministry of Health

29 February 2012 - New Zealand Maternity Clinical Indicators 2009 - The New Zealand Maternity Clinical Indicators are an integral part of the Ministry of Health's Maternity Quality Initiative. These indicators are evidence-based and cover a range of procedures and outcomes for mothers and their babies. This benchmarked data will be used to support the local clinical review of maternity services.

28 February 2012 - The Environmental Case Management of Lead-Exposed Persons - These guidelines help public health units to determine the risk of a lead hazards and gives appropriate advice on managing the risk, including risk communication. These revised guidelines build on the 1998 and 2007 editions.

28 February 2012 - A Focus on Maori nutrition - This report presents key findings for Maori from the 2008/09 New Zealand Adult Nutrition Survey, including energy and nutrient intake, dietary supplement use, eating patterns, food security and nutritionrelated health (eg body size, blood pressure and diabetes).

28 February 2012 - A Focus on Pacific Nutrition - This report presents key findings for Pacific peoples from the 2008/09 New Zealand Adult Nutrition Survey, including energy and nutrient intake, dietary supplement use, eating patterns, food security and nutritionrelated health (eg body size, blood pressure and diabetes).

28 February 2012 - Guidance on Surveillance for People at Increased Risk of Colorectal Cancer - This guideline provides evidence-based surveillance recommendations for people at increased risk of colorectal cancer. It updates the 2004 publication Surveillance and Management of Groups at Increased Risk of Colorectal Cancer. It is intended for primary and secondary care providers.

28 February 2012 - Bowel cancer: information for people at increased risk of bowel cancer - Bowel cancer is the second-most common cancer in both men and women in New Zealand.

United Kingdom. Department of Health

Over £100 million given to support groundbreaking clinical research - Over £100m will be invested in NHS clinical research facilities to develop new treatments to benefit thousands of patients. The money, provided by the National Institute for Health Research, will be ... Read more – Over £100 million given to support groundbreaking clinical research

£22 million for ground-breaking children's mental health programme - Up to £22m will be pumped into a pioneering programme to give children with mental health problems access to the best available services in a wider range of places. The ... Read more – £22 million for ground-breaking children's mental health programme

New site to take you inside government - A new test version of a single website for government was made live today. "Inside government" is the corporate platform that will be for specialists seeking a "behind the scenes"... Read more – New site to take you inside government

UK Plan for rare diseases consultation launched - Earlier diagnosis of a rare condition and better coordinated care will help improve the quality of life for people with rare diseases and their families, according to the first ever ... Read more – UK Plan for rare diseases consultation launched

Paul Burstow to take part in Gransnet webchat - Minister for Care Services, Paul Burstow will be taking part in a live webchat on Gransnet, the social networking site for grandparents. The chat with the Minister and the Townswomen's ... Read more – Paul Burstow to take part in Gransnet webchat

Latest topics referred to NICE: January 2012 - Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE) in January, to begin the process of developing guidance for ... Read more – Latest topics referred to NICE: January 2012

Webchat on autism - On Wednesday 7 March at 2pm, David Behan, Director General for Social Care, Local Government and Care Partnerships will host a webchat with Mark Lever, Chief Executive of the National Autistic Society on issues ... Read more – Webchat on autism

Acting FAST can save hundreds of lives - A campaign set to save the lives of stroke victims from across the country launches today. These hard hitting adverts, which will run until 25 March, aim to get people ... Read more – Acting FAST can save hundreds of lives

Government response to report on public expenditure - Today, the Government published its response to the Health Select Committee report on public expenditure. The Committee's report followed an inquiry into the implications for health and social care services ... Read more – Government response to report on public expenditure

United States of America. Department of Health & Human Services

1 March 2012 - Statement from Secretary Kathleen Sebelius on Women's History Month - Women's History Month is an important time of reflection and celebration for all Americans. We recognise the extraordinary accomplishments of women throughout history, and we celebrate the power of their vital contributions to shape our Nation's future.

29 February 2012 - HHS Statement on Cigarette Health Warning Ruling - This Administration is determined to do everything we can to warn young people about the dangers of smoking, which remains the leading cause of preventable death in America.

28 February 2012 - HHS Secretary Sebelius announces environmental justice strategy - Health & Human Services Secretary, Kathleen Sebelius, along with other federal agencies, today released the Department's 2012 Environmental Justice Strategy and Implementation Plan, outlining steps that will be taken to protect communities facing greater health and environmental risks.

24 February 2012 - Secretary Sebelius announces next stage for providers adopting electronic health records - Health and Human Services Secretary, Kathleen Sebelius today announced the next steps for providers who are using electronic health record technology and receiving incentive payments from Medicare and Medicaid.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions